No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Why the Global Cancer Market Could Surpass $900 Billion--And the Stocks Leading the Charge
All You Need to Know About Cardiff Oncology (CRDF) Rating Upgrade to Buy
Cardiff Oncology Full Year 2024 Earnings: Beats Expectations
H.C. Wainwright Initiates Cardiff Oncology(CRDF.US) With Buy Rating, Announces Target Price $17
Piper Sandler Maintains Cardiff Oncology(CRDF.US) With Buy Rating, Maintains Target Price $10
Cardiff Oncology's Earnings Call: Optimism Amid Challenges